AIRA Matrix USCAPAIRA Matrix invites you to the 111th USCAP Annual Meeting, Los Angeles where we exhibit our novel Prostate Cancer Decision Support Suite from 21-23 March 2022.

The suite comprising diagnostic, prognostic, and predictive solutions provides accurate disease stratification and enables management protocols tailored to improve treatment outcomes. The suite includes solutions for improved accuracy of mpMRI reporting by learning from pathology-derived ground truth.

For more information, visit Booth #234 at the USCAP event; alternatively, email us at info@airamatrix.com

About AIRA Matrix:

AIRA Matrix provides Artificial Intelligence solutions for Life Sciences applications. Our products and services improve efficiency, diagnostic accuracy and turnaround times in pathology laboratory workflows. Our diagnostic, prognostic and predictive solutions for cancer care aid disease stratification and enable management protocols tailored to improve treatment outcomes.

Our clients and partners include leading hospitals, pharmaceutical companies, CROs and research labs around the world.

Do check us out at https://www.airamatrix.com.

SOURCE: AIRA Matrix

OR

platinum partners

gold partners

Silver Partners

Media Partners